Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Catheter Evaluation for Endocardial Ablation in Patients With Ventricular Tachycardia

Study:

NaviStar ThermoCool Catheter for Endocardial RF Ablation in Patients With Ventricular Tachycardia

Rationale:

n/a

Purpose:

The primary objective is to provide additional corroborative safety and efficacy data for the Navistar ThermoCool catheter for the treatment of subjects with ischemic Ventricular Tachycardia.

Study Status: Active, not recruiting

Recruiting:
n/a

Condition Intervention Phase
Ventricular Tachycardia Device: NAVISTAR® THERMOCOOL® Catheter Phase 4

Verified by Biosense Webster, Inc. September, 2011

Sponsored by: Biosense Webster, Inc.
Information provided by: Biosense Webster, Inc.
ClinicalTrials.gov identifier: NCT00412607

Study Type: Interventional

Study Design: Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States

n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site